HUP0103947A2 - Egy piridopirazinszármazék metán-szulfonát sója és annak kristályai és ezek gyógyászati alkalmazása - Google Patents

Egy piridopirazinszármazék metán-szulfonát sója és annak kristályai és ezek gyógyászati alkalmazása

Info

Publication number
HUP0103947A2
HUP0103947A2 HU0103947A HUP0103947A HUP0103947A2 HU P0103947 A2 HUP0103947 A2 HU P0103947A2 HU 0103947 A HU0103947 A HU 0103947A HU P0103947 A HUP0103947 A HU P0103947A HU P0103947 A2 HUP0103947 A2 HU P0103947A2
Authority
HU
Hungary
Prior art keywords
crystals
novel
pharmaceutical use
compound
methanesulfonate salts
Prior art date
Application number
HU0103947A
Other languages
English (en)
Inventor
Masaharu Ichihara
Kooji Kagara
Nobutaka Kawai
Koji Machiya
Norihiko Shimazaki
Masaru Watanabe
Original Assignee
Fujisawa Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co., Ltd. filed Critical Fujisawa Pharmaceutical Co., Ltd.
Publication of HUP0103947A2 publication Critical patent/HUP0103947A2/hu
Publication of HUP0103947A3 publication Critical patent/HUP0103947A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

A jelen tal lm ny t rgya (I) képletű piridopirazinsz rmazék sója, ésannak krist lymódosulata. A tal lm ny t rgya k"zelebbről, a fentiképletű vegyület, annak szolv tja és krist lyai és ezek gyógy szatialkalmaz sa. Ó
HU0103947A 1998-09-29 1999-09-22 Novel methanesulfonate salts of pyridopyrazine compound and crystals thereof and their pharmaceutical use HUP0103947A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27444098 1998-09-29
PCT/JP1999/005182 WO2000018768A1 (fr) 1998-09-29 1999-09-22 Nouveaux sels d'un compose de pyridopyrazine et cristaux desdits sels

Publications (2)

Publication Number Publication Date
HUP0103947A2 true HUP0103947A2 (hu) 2002-04-29
HUP0103947A3 HUP0103947A3 (en) 2002-06-28

Family

ID=17541719

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103947A HUP0103947A3 (en) 1998-09-29 1999-09-22 Novel methanesulfonate salts of pyridopyrazine compound and crystals thereof and their pharmaceutical use

Country Status (13)

Country Link
EP (1) EP1118615A4 (hu)
KR (1) KR20010075287A (hu)
CN (1) CN1328555A (hu)
AU (1) AU5758199A (hu)
BR (1) BR9914399A (hu)
CA (1) CA2345362A1 (hu)
CZ (1) CZ20011164A3 (hu)
HK (1) HK1042896A1 (hu)
HU (1) HUP0103947A3 (hu)
IL (1) IL142147A0 (hu)
TR (2) TR200200971T2 (hu)
WO (1) WO2000018768A1 (hu)
ZA (1) ZA200102566B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EP1511516B1 (en) * 2002-05-28 2008-12-17 Nycomed GmbH Topically applicable pharmaceutical preparation
JP2006501269A (ja) * 2002-09-16 2006-01-12 アルコン マニュファクチャリング，リミティド 血管新生を処置するためのｐｄｅｉｖインヒビターの使用
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
CA2601250C (en) 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
KR20120073300A (ko) * 2009-09-30 2012-07-04 뗑따마르 에스아에스 휴대 가방 또는 조끼

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008864A1 (en) * 1978-08-15 1980-03-19 FISONS plc Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them
AU594512B2 (en) * 1986-09-16 1990-03-08 Merck Patent Gesellschaft Mit Beschrankter Haftung Hydroxy indole derivatives
GB9413975D0 (en) * 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives

Also Published As

Publication number Publication date
CN1328555A (zh) 2001-12-26
WO2000018768A1 (fr) 2000-04-06
EP1118615A4 (en) 2002-02-27
BR9914399A (pt) 2002-01-22
ZA200102566B (en) 2002-07-18
CA2345362A1 (en) 2000-04-06
HUP0103947A3 (en) 2002-06-28
KR20010075287A (ko) 2001-08-09
IL142147A0 (en) 2002-03-10
EP1118615A1 (en) 2001-07-25
HK1042896A1 (zh) 2002-08-30
AU5758199A (en) 2000-04-17
TR200100893T2 (tr) 2001-11-21
CZ20011164A3 (cs) 2001-12-12
TR200200971T2 (tr) 2002-06-21

Similar Documents

Publication Publication Date Title
HUP0202655A2 (hu) N-[(amino-imino-metil)- és N-[(amino-metil)-fenil]-propil-amid származékok
NO20093253L (no) Forbindelser, farmasoytiske formuleringer og anvendelse av forbindelsene til fremstilling av legemiddel
HUP0102813A2 (hu) Perindopril-terc-butil-amin-só új béta-kristályos formája, eljárás ennek előállítására és ezt tartalmazó gyógyászati készítmények
NO903851D0 (no) Fremgangsmaate for fremstilling av n-substituerte-4-pyrimidinaminer og -pyrimidindiaminer, og deres anvendelse som medikamenter.
TR200002953T2 (tr) İki halkalı hidroksamik asit türevleri
NO179867C (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider og anvendelse av forbindelsene som legemidler
DK205789A (da) Optisk aktive pyridoncarboxylsyrederivater og laegemidler indeholdende disse
NO2005019I2 (no) Metylaminolevulinat, eventuelt i form av et salt, fortrinnsvis metylaminolevulinat-hydroklorid
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
HUP9701059A2 (hu) Stronciumsók alkalmazása ízületi bántalmak kezelésére alkalmas gyógyszerkészítmények előállítására
ES8801631A1 (es) Un procedimiento para preparar derivados de (benzoil-4-piperidinil-1)-2-fenil-1-alcanoles
NO20022558L (no) 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor
NO963370D0 (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
NO861366L (no) N-indolyletylsulfonsyreamider og fremgangsmaater til fremstilling derav.
DK581889A (da) Antiatherosclerotiske diarylforbindelser
HUP0103947A2 (hu) Egy piridopirazinszármazék metán-szulfonát sója és annak kristályai és ezek gyógyászati alkalmazása
ATE361918T1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2- yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
NO981204L (no) Selektive <beta>3 -adrenergiske agonister
CO4940452A1 (es) Modificacion a cristal de una sustancia activa de medicamen- to
HUP0300295A2 (hu) Helyettesített benzamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DK0648202T3 (da) Substituerede (arylalkylaminobenzyl)aminopropanamidderivater, fremstilling deraf og anvendelse som anti-epileptiske, neurobeskyttende og antidepressive midler
HUP9702448A2 (hu) Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény
HUP9904030A2 (hu) Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására
SV1998000088A (es) Compuestos farmaceuticos
SE9802538D0 (sv) New pharmaceutically active compounds